BRIEF—Tiziana Life Sciences announces CEO resignation

USA-based biotech Tiziana Life Sciences announced that its board of directors has accepted the voluntary resignation of Dr Kunwar Shailubhai as chief, chief scientific officer and board director, effective as of August 1, 2022.

Dr Shailubhai resigned for personal reasons, and his resignation is not related to any disagreement with the company on any matter relating to the company’s operations, policies or practices.

The board has appointed Gabriele Cerrone, executive chairman of Tiziana, as interim CEO to lead the company through this period of transition.

The board will begin a search for a permanent chief executive and chief scientific officer immediately.